Estrella Immunopharma Statistics
Total Valuation
ESLA has a market cap or net worth of $20.36 million. The enterprise value is $20.21 million.
| Market Cap | 20.36M |
| Enterprise Value | 20.21M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, after market close.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ESLA has 43.50 million shares outstanding. The number of shares has increased by 10.44% in one year.
| Current Share Class | 43.50M |
| Shares Outstanding | 43.50M |
| Shares Change (YoY) | +10.44% |
| Shares Change (QoQ) | +2.08% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 1.89% |
| Float | 38.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.20
| Current Ratio | 0.20 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -251.86% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 130.29% |
| Weighted Average Cost of Capital (WACC) | 9.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -25 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.07% in the last 52 weeks. The beta is 0.89, so ESLA's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -65.07% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 31.15 |
| Average Volume (20 Days) | 44,141 |
Short Selling Information
The latest short interest is 153,781, so 0.35% of the outstanding shares have been sold short.
| Short Interest | 153,781 |
| Short Previous Month | 117,132 |
| Short % of Shares Out | 0.35% |
| Short % of Float | 0.40% |
| Short Ratio (days to cover) | 4.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.68M |
| Pretax Income | -10.01M |
| Net Income | -10.01M |
| EBITDA | n/a |
| EBIT | -9.68M |
| Earnings Per Share (EPS) | -$0.25 |
Balance Sheet
The company has $146,670 in cash and no debt, with a net cash position of $146,670 or $0.00 per share.
| Cash & Cash Equivalents | 146,670 |
| Total Debt | n/a |
| Net Cash | 146,670 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | -7.43M |
| Book Value Per Share | -0.17 |
| Working Capital | -7.43M |
Cash Flow
| Operating Cash Flow | -9.38M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -9.38M |
| FCF Per Share | -$0.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ESLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.44% |
| Shareholder Yield | -10.44% |
| Earnings Yield | -49.19% |
| FCF Yield | -46.10% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |